138 related articles for article (PubMed ID: 35281653)
1. Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by HIPP-Werk Georg Hipp OHG (dossier submitted by meyer.science GmbH).
; Bohn T; Castenmiller J; de Henauw S; Hirsch-Ernst KI; Katrine Knutsen H; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Bresson JL; Castle L; Fewtrell M; Przyrembel H; Dumas C; Titz A; Turck D
EFSA J; 2022 Mar; 20(3):e07141. PubMed ID: 35281653
[TBL] [Abstract][Full Text] [Related]
2. Nutritional safety and suitability of a specific protein hydrolysate derived from whey protein concentrate and used in an infant and follow-on formula manufactured from hydrolysed protein by Danone Trading ELN B.V.
; Castenmiller J; de Henauw S; Hirsch-Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Bresson JL; Castle L; Fewtrell M; Przyrembel H; Dumas C; Titz A; Turck D
EFSA J; 2020 Nov; 18(11):e06304. PubMed ID: 33312234
[TBL] [Abstract][Full Text] [Related]
3. Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland B.V.
; Bohn T; Castenmiller J; de Henauw S; Hirsch-Ernst KI; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Bresson JL; Castle L; Fewtrell M; Przyrembel H; Dumas C; Titz A; Turck D
EFSA J; 2023 Jul; 21(7):e08063. PubMed ID: 37469354
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis.
; Castenmiller J; Hirsch-Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Turck D; Vinceti M; Marchelli R; van Loveren H; Dumas C; Titz A; de Henauw S
EFSA J; 2021 Jun; 19(6):e06603. PubMed ID: 34140987
[TBL] [Abstract][Full Text] [Related]
5. Scientific Opinion on the safety and suitability for use by infants of follow-on formulae with a protein content of at least 1.6 g/100 kcal.
; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Valtueña Martínez S
EFSA J; 2017 May; 15(5):e04781. PubMed ID: 32625487
[TBL] [Abstract][Full Text] [Related]
6. Safety and Suitability of an Infant Formula Manufactured from Extensively Hydrolysed Protein in Healthy Term Infants.
Otten L; Schelker E; Petersen H; Nomayo A; Fleddermann M; Arendt BM; Britzl T; Haberl EM; Jochum F;
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111119
[TBL] [Abstract][Full Text] [Related]
7. Safety of bovine milk osteopontin as a Novel food pursuant to Regulation (EU) 2015/2283.
; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Maradona MP; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Schlatter JR; van Loveren H; Gelbmann W; Knutsen HK
EFSA J; 2022 May; 20(5):e07137. PubMed ID: 35572202
[TBL] [Abstract][Full Text] [Related]
8. The German Infant Nutritional Intervention Study (GINI) for the preventive effect of hydrolyzed infant formulas in infants at high risk for allergic diseases. Design and selected results.
von Berg A; Filipiak-Pittroff B; Krämer U; Link E; Heinrich J; Koletzko S; Grübl A; Hoffmann U; Beckmann C; Reinhardt D; Bauer CP; Wichmann E; Berdel D
Allergol Select; 2017; 1(1):28-38. PubMed ID: 30402599
[TBL] [Abstract][Full Text] [Related]
9. Safety of partially hydrolysed protein from spent barley (
; Turck D; Aguilera-Gómez M; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Frenzel T; Heinonen M; Prieto Maradona M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Siskos A; Schlatter JR; van Loveren H; Zakidou P; Mendes V; Ververis E; Knutsen HK
EFSA J; 2023 Sep; 21(9):e08064. PubMed ID: 37663172
[TBL] [Abstract][Full Text] [Related]
10. Scientific and technical guidance for the preparation and presentation of a dossier for evaluation of an infant and/or follow-on formula manufactured from protein hydrolysates (Revision 1).
; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Loveren HV; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Martínez SV
EFSA J; 2021 Mar; 19(3):e06556. PubMed ID: 33791040
[TBL] [Abstract][Full Text] [Related]
11. Five-year follow-up of high-risk infants with family history of allergy who were exclusively breast-fed or fed partial whey hydrolysate, soy, and conventional cow's milk formulas.
Chandra RK
J Pediatr Gastroenterol Nutr; 1997 Apr; 24(4):380-8. PubMed ID: 9144119
[TBL] [Abstract][Full Text] [Related]
12. Formulas containing hydrolysed protein for prevention of allergy and food intolerance in infants.
Osborn DA; Sinn J
Cochrane Database Syst Rev; 2006 Oct; (4):CD003664. PubMed ID: 17054180
[TBL] [Abstract][Full Text] [Related]
13. Determination of allergenicity to three cow's milk hydrolysates and an amino acid-derived formula in children with cow's milk allergy.
Caffarelli C; Plebani A; Poiesi C; Petroccione T; Spattini A; Cavagni G
Clin Exp Allergy; 2002 Jan; 32(1):74-9. PubMed ID: 12002741
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro studies on the residual allergenicity of partially hydrolysed infant formulae.
Niggemann B; Binder C; Klettke U; Wahn U
Acta Paediatr; 1999 Apr; 88(4):394-8. PubMed ID: 10342536
[TBL] [Abstract][Full Text] [Related]
15. Calcium l-methylfolate as a source of folate added for nutritional purposes to infant and follow-on formula, baby food and processed cereal-based food.
; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Cubadda F; Engel KH; Frenzel T; Heinonen M; Marchelli R; Neuhäuser-Berthold M; Poulsen M; Sanz Y; Schlatter JR; van Loveren H; Bernasconi G; Germini A; Knutsen HK
EFSA J; 2020 Jan; 18(1):e05947. PubMed ID: 32626499
[TBL] [Abstract][Full Text] [Related]
16. Nutritional evaluation of protein hydrolysate formulas.
Rigo J; Salle BL; Picaud JC; Putet G; Senterre J
Eur J Clin Nutr; 1995 Sep; 49 Suppl 1():S26-38. PubMed ID: 8647061
[TBL] [Abstract][Full Text] [Related]
17. A perspective on partially hydrolyzed protein infant formula in nonexclusively breastfed infants.
Vandenplas Y; Munasir Z; Hegar B; Kumarawati D; Suryawan A; Kadim M; Djais JT; Basrowi RW; Krisnamurti D
Korean J Pediatr; 2019 May; 62(5):149-154. PubMed ID: 30651423
[TBL] [Abstract][Full Text] [Related]
18. Safety of Whey basic protein isolates as a novel food pursuant to Regulation (EU) 2015/2283.
; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Schlatter JR; Amundsen M; van Loveren H
EFSA J; 2018 Jul; 16(7):e05360. PubMed ID: 32625992
[TBL] [Abstract][Full Text] [Related]
19. Protein hydrolysate versus standard formula for preterm infants.
Ng DHC; Klassen JR; Embleton ND; McGuire W
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD012412. PubMed ID: 31339557
[TBL] [Abstract][Full Text] [Related]
20. Safety and Suitability of Infant Formula Manufactured from Extensively Hydrolyzed Whey Protein Compared to Intact Protein: A Combined Analysis of Two Randomized Controlled Studies.
Fleddermann M; Knoll A; Koletzko B
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
